Grifols, S.A. (GRFS)

NMS – Real vaqt narxi. Valyuta: USD

7.56

-0.24 (-3.08%)

Yopilishda: May 12, 2026, 4:00 PM EDT

09.05.2026

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript

30.03.2026

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

OTTAWA, March 30, 2026 (GLOBE NEWSWIRE) -- Proponents of public universal health care across Canada are calling for the closure of Grifols facilities in the wake of two deaths in Winnipeg of people who sold their plasma to the giant multinational. A third person is suing the hugely profitable Grifols for kidney damage from a plasma sale. Health Canada also reports non-compliance at four other Grifols sites.

24.03.2026

Grifols approves IPO of its US biopharma business

Healthcare company Grifols ‌said on Tuesday it ⁠has approved a U.S. initial public offering of ‌its ⁠U.S. biopharma business.

17.03.2026

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared proof-of-concept data from its Chronos-PD program, demonstrating that biological changes in individuals with Parkinson's disease (PD) occur more than a decade before clinical diagnosis, with potential future implications for early detection and intervention.

13.03.2026

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) -- The Ontario and Manitoba Health Coalitions held a press conference this morning to respond to a report from CBC about two patients who died in Winnipeg after having their blood plasma harvested at centres owned by for-profit pharmaceutical corporation Grifols. Another report followed, of a man who is suing , alleging kidney damage from equipment failure while having his plasma harvested at a Grifols centre. The Alberta Friends of Medicare revealed that Grifols has been found non-compliant with serious breaches at their Calgary centre. Inspection reports from Health Canada show that four Grifols centres have been found non-compliant in Calgary , Alberta; St. John , New Brunswick; and Regina and Saskatoon , Saskatchewan.

12.03.2026

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

WINNIPEG, Manitoba and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- What: Spokespeople from the Manitoba Health Coalition and Ontario Health Coalition will respond to the sad news of two deaths of paid “donors” at for-profit plasma collection facilities owned by pharma giant Grifols. The Coalitions have long raised warnings about safety and the ownership and control of the blood system.

12.03.2026

Grifols: I'm Very Happy To Add In 2026

Grifols is a global leader in blood plasma, now rated 'BUY' with a €20/share PT and $23/share ADR target. GRFS has delivered €450M in cost savings, 150%+ net profit growth, and FCF exceeding guidance, with leverage down to 4.2x. Despite a BB- rating, improved fundamentals, dividend reinstatement, and forecasted 20–25% annual growth support a strong risk/reward profile.

Videolar

No Data

There is no data to display

Press-relizlar

30.03.2026

Grifols, S.A. (GRFS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Grifols, S.A. (GRFS)

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols approves IPO of its US biopharma business

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Grifols: I'm Very Happy To Add In 2026

Videolar

No Data

Press-relizlar

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols approves IPO of its US biopharma business

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Grifols: I'm Very Happy To Add In 2026

Videolar

No Data

Press-relizlar

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Search stocks

Grifols, S.A. (GRFS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Grifols, S.A. (GRFS)

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols approves IPO of its US biopharma business

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Grifols: I'm Very Happy To Add In 2026

Videolar

No Data

Press-relizlar

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols approves IPO of its US biopharma business

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites

Grifols: I'm Very Happy To Add In 2026

Videolar

No Data

Press-relizlar

Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates

Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease

Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance

Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites